The changing face of community-acquired methicillin-resistant Staphylococcus aureus

Indian Journal of Medical Microbiology

Volumn 34, Issue 3, 2016, Pages 275-285

  Kale, P ^a   Dhawan, B ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Changing trend; community acquired methicillin resistant Staphylococcus aureus; molecular epidemiology; nosocomial

Indexed keywords

ALPHA TOXIN; ANTIBIOTIC AGENT; ARGININE CATABOLIC MOBILE ELEMENT; BACTERIAL PROTEIN; ELEMENT; PANTON VALENTINE LEUKOCIDIN; PHENOL SOLUBLE MODULIN; PROTEIN A; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIAL VIRULENCE; BACTERIUM DETECTION; COMMUNITY ACQUIRED METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; COMMUNITY ACQUIRED PNEUMONIA; GENETIC TRAIT; GENOTYPE; HOSPITAL PATIENT; HUMAN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MOLECULAR EPIDEMIOLOGY; MOLECULAR TYPING; NONHUMAN; REVIEW; RISK FACTOR; SOFT TISSUE INFECTION; STAPHYLOCOCCAL SKIN INFECTION; CLASSIFICATION; COMMUNITY-ACQUIRED INFECTIONS; GENETICS; GENOTYPING TECHNIQUE; ISOLATION AND PURIFICATION; MICROBIOLOGY; STAPHYLOCOCCAL INFECTIONS;

COMMUNITY-ACQUIRED INFECTIONS; GENOTYPING TECHNIQUES; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MOLECULAR EPIDEMIOLOGY; STAPHYLOCOCCAL INFECTIONS;

EID: 84984617601     PISSN: 02550857     EISSN: 19983646     Source Type: Journal    
DOI: 10.4103/0255-0857.188313     Document Type: Review

References (86)

1. Deresinski S. Methicillin-resistant Staphylococcus aureus: An evolutionary, epidemiologic, and therapeutic odyssey. Clin Infect Dis 2005;40:562-73.
2. Graffunder EM, Venezia RA. Risk factors associated with nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection including previous use of antimicrobials. J Antimicrob Chemother 2002;49:999-1005.
3. Salgado CD, Farr BM, Calfee DP. Community-acquired methicillin-resistant Staphylococcus aureus: A meta-analysis of prevalence and risk factors. Clin Infect Dis 2003;36:131-9.
4. Herold BC, Immergluck LC, Maranan MC, Lauderdale DS, Gaskin RE, Boyle-Vavra S, et al. Communityacquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA 1998;279:593-8.
5. Gorak EJ, Yamada SM, Brown JD. Community-acquired methicillin-resistant Staphylococcus aureus in hospitalized adults and children without known risk factors. Clin Infect Dis 1999;29:797-800.
6. Naimi TS, LeDell KH, Boxrud DJ, Groom AV, Steward CD, Johnson SK, et al. Epidemiology and clonality of communityacquired methicillin-resistant Staphylococcus aureus in Minnesota, 1996-1998. Clin Infect Dis 2001;33:990-6.
7. Vandenesch F, Naimi T, Enright MC, Lina G, Nimmo GR, Heffernan H, et al. Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: Worldwide emergence. Emerg Infect Dis 2003;9:978-84.
8. Wannet WJ, Heck ME, Pluister GN, Spalburg E, van Santen MG, Huijsdans XW, et al. Panton-Valentine leukocidin positive MRSA in 2003: The Dutch situation. Euro Surveill 2004;9:28-9.
9. Harbarth S, François P, Shrenzel J, Fankhauser-Rodriguez C, Hugonnet S, Koessler T, et al. Community-associated methicillin-resistant Staphylococcus aureus, Switzerland. Emerg Infect Dis 2005;11:962-5.
10. Witte W, Braulke C, Cuny C, Strommenger B, Werner G, Heuck D, et al. Emergence of methicillin-resistant Staphylococcus aureus with Panton-Valentine leukocidin genes in central Europe. Eur J Clin Microbiol Infect Dis 2005;24:1-5.
11. Müller-Premru M, Strommenger B, Alikadic N, Witte W, Friedrich AW, Seme K, et al. New strains of communityacquired methicillin-resistant Staphylococcus aureus with Panton-Valentine leukocidin causing an outbreak of severe soft tissue infection in a football team. Eur J Clin Microbiol Infect Dis 2005;24:848-50.
12. Denis O, Deplano A, De Beenhouwer H, Hallin M, Huysmans G, Garrino MG, et al. Polyclonal emergence and importation of community-acquired methicillin-resistant Staphylococcus aureus strains harbouring Panton-Valentine leucocidin genes in Belgium. J Antimicrob Chemother 2005;56:1103-6.
13. Okuma K, Iwakawa K, Turnidge JD, Grubb WB, Bell JM, O'Brien FG, et al. Dissemination of new methicillin-resistant Staphylococcus aureus clones in the community. J Clin Microbiol 2002;40:4289-94.
14. Fridkin SK, Hageman JC, Morrison M, Sanza LT, Como-Sabetti K, Jernigan JA, et al. Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med 2005;352:1436-44.
15. Skiest DJ, Brown K, Cooper TW, Hoffman-Roberts H, Mussa HR, Elliott AC. Prospective comparison of methicillinsusceptible and methicillin-resistant community-associated Staphylococcus aureus infections in hospitalized patients. J Infect 2007;54:427-34.
16. Cohen PR, Kurzrock R. Community-acquired methicillinresistant Staphylococcus aureus skin infection: An emerging clinical problem. J Am Acad Dermatol 2004;50:277-80.
17. Francis JS, Doherty MC, Lopatin U, Johnston CP, Sinha G, Ross T, et al. Severe community-onset pneumonia in healthy adults caused by methicillin-resistant Staphylococcus aureus carrying the Panton-Valentine leukocidin genes. Clin Infect Dis 2005;40:100-7.
18. Seybold U, Kourbatova EV, Johnson JG, Halvosa SJ, Wang YF, King MD, et al. Emergence of communityassociated methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of health care-associated blood stream infections. Clin Infect Dis 2006;42:647-56.
19. Miller LG, Perdreau-Remington F, Rieg G, Mehdi S, Perlroth J, Bayer AS, et al. Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles. N Engl J Med 2005;352:1445-53.
20. Klevens RM, Morrison MA, Nadle J, Petit S, Gershman K, Ray S, et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 2007;298:1763-71.
21. Otter JA, French GL. Community-associated meticillinresistant Staphylococcus aureus: The case for a genotypic definition. J Hosp Infect 2012;81:143-8.
22. de Lencastre H, Oliveira D, Tomasz A. Antibiotic resistant Staphylococcus aureus: A paradigm of adaptive power. Curr Opin Microbiol 2007;10:428-35.
23. Ito T, Kuwahara-Arai K, Katayama Y, Uehara Y, Han X, Kondo Y, et al. Staphylococcal cassette chromosome mec (SCCmec) analysis of MRSA in methicillin-resistant Staphylococcus aureus (MRSA) protocols. Totowa, NJ: Humana Press; 2014. p. 131-48.
24. Udo EE, Pearman JW, Grubb WB. Genetic analysis of community isolates of methicillin-resistant Staphylococcus aureus in Western Australia. J Hosp Infect 1993;25:97-108.
25. Stefani S, Chung DR, Lindsay JA, Friedrich AW, Kearns AM, Westh H, et al. Meticillin-resistant Staphylococcus aureus (MRSA): Global epidemiology and harmonisation of typing methods. Int J Antimicrob Agents 2012;39:273-82.
26. DeLeo FR, Otto M, Kreiswirth BN, Chambers HF. Community-associated meticillin-resistant Staphylococcus aureus. Lancet 2010;375:1557-68.
27. David MZ, Daum RS. Community-associated methicillinresistant Staphylococcus aureus: Epidemiology and clinical consequences of an emerging epidemic. Clin Microbiol Rev 2010;23:616-87.
28. Nichol KA, Adam HJ, Hussain Z, Mulvey MR, McCracken M, Mataseje LF, et al. Comparison of community-associated and health care associated methicillin-resistant Staphylococcus aureus in Canada: Results of the CANWARD 2007-2009 study. Diagn Microbiol Infect Dis 2011;69:320-5.
29. Sola C, Saka HA; Cordoba MRSA Collaborative Study Group, Vindel A, Bocco JL. Emergence and dissemination of a community-associated methicillin-resistant Panton-Valentine leucocidin-positive Staphylococcus aureus clone sharing the sequence type 5 lineage with the most prevalent nosocomial clone in the same region of Argentina. J Clin Microbiol 2008;46:1826-31.
30. Witte W. Community-acquired methicillin-resistant Staphylococcus aureus: What do we need to know? Clin Microbiol Infect 2009;15 Suppl 7:17-25.
31. Monecke S, Coombs G, Shore AC, Coleman DC, Akpaka P, Borg M, et al. A field guide to pandemic, epidemic and sporadic clones of methicillin-resistant Staphylococcus aureus. PLoS One 2011;6:e17936.
32. Abdulgader SM, Shittu AO, Nicol MP, Kaba M. Molecular epidemiology of methicillin-resistant Staphylococcus aureus in Africa: A systematic review. Front Microbiol 2015;6:348.
33. Chuang YY, Huang YC. Molecular epidemiology of community-associated meticillin-resistant Staphylococcus aureus in Asia. Lancet Infect Dis 2013;13:698-708.
34. Gadepalli R, Dhawan B, Kapil A, Sreenivas V, Jais M, Gaind R, et al. Clinical and molecular characteristics of nosocomial meticillin-resistant Staphylococcus aureus skin and soft tissue isolates from three Indian hospitals. J Hosp Infect 2009;73:253-63.
35. Arakere G, Nadig S, Swedberg G, Macaden R, Amarnath SK, Raghunath D. Genotyping of methicillinresistant Staphylococcus aureus strains from two hospitals in Bangalore, South India. J Clin Microbiol 2005;43:3198-202.
36. Shabir S, Hardy KJ, Abbasi WS, McMurray CL, Malik SA, Wattal C, et al. Epidemiological typing of meticillin-resistant Staphylococcus aureus isolates from Pakistan and India. J Med Microbiol 2010;59(Pt 3):330-7.
37. Abimanyu N, Murugesan S, Krishnan P. Emergence of methicillin-resistant Staphylococcus aureus ST239 with highlevel mupirocin and inducible clindamycin resistance in a tertiary care center in Chennai, South India. J Clin Microbiol 2012;50:3412-3.
38. Chambers HF, Deleo FR. Waves of resistance: Staphylococcus aureus in the antibiotic era. Nat Rev Microbiol 2009;7:629-41.
39. Monecke S, Baier V, Coombs GW, Slickers P, Ziegler A, Ehricht R. Genome sequencing and molecular characterisation of Staphylococcus aureus ST772-MRSA-V, "Bengal Bay Clone". BMC Res Notes 2013;6:548.
40. Shambat S, Nadig S, Prabhakara S, Bes M, Etienne J, Arakere G. Clonal complexes and virulence factors of Staphylococcus aureus from several cities in India. BMC Microbiol 2012;12:64.
41. Kraus D, Peschel A. Staphylococcus aureus evasion of innate antimicrobial defense. Future Microbiol 2008;3:437-51.
42. Foster TJ. Immune evasion by staphylococci. Nat Rev Microbiol 2005;3:948-58.
43. Li M, Diep BA, Villaruz AE, Braughton KR, Jiang X, DeLeo FR, et al. Evolution of virulence in epidemic community-associated methicillin-resistant Staphylococcus aureus. Proc Natl Acad Sci U S A 2009;106:5883-8.
44. Genestier AL, Michallet MC, Prévost G, Bellot G, Chalabreysse L, Peyrol S, et al. Staphylococcus aureus Panton-Valentine leukocidin directly targets mitochondria and induces Bax-independent apoptosis of human neutrophils. J Clin Invest 2005;115:3117-27.
45. Thurlow LR, Joshi GS, Richardson AR. Virulence strategies of the dominant USA300 lineage of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA). FEMS Immunol Med Microbiol 2012;65:5-22.
46. Boan P, Tan HL, Pearson J, Coombs G, Heath CH, Robinson JO, et al. Epidemiological, clinical, outcome and antibiotic susceptibility differences between PVL positive and PVL negative Staphylococcus aureus infections in Western Australia: A case control study. BMC Infect Dis 2015;15:10.
47. Otto M. Community-associated MRSA: What makes them special? Int J Med Microbiol 2013;303:324-30.
48. Craven RR, Gao X, Allen IC, Gris D, Bubeck Wardenburg J, McElvania-Tekippe E, et al. Staphylococcus aureus alphahemolysin activates the NLRP3-inflammasome in human and mouse monocytic cells. PLoS One 2009;4:e7446.
49. Arsic B, Zhu Y, Heinrichs DE, McGavin MJ. Induction of the staphylococcal proteolytic cascade by antimicrobial fatty acids in community acquired methicillin resistant Staphylococcus aureus. PLoS One 2012;7:e45952.
50. Crum NF, Lee RU, Thornton SA, Stine OC, Wallace MR, Barrozo C, et al. Fifteen-year study of the changing epidemiology of methicillin-resistant Staphylococcus aureus. Am J Med 2006;119:943-51.
51. Popovich KJ, Weinstein RA. Commentary: The graying of methicillin-resistant Staphylococcus aureus. Infect Control Hosp Epidemiol 2009;30:9-12.
52. Otter JA, French GL. Nosocomial transmission of community-associated methicillin-resistant Staphylococcus aureus: An emerging threat. Lancet Infect Dis 2006;6:753-5.
53. Otter JA, French GL. Community-associated meticillinresistant Staphylococcus aureus strains as a cause of healthcare-associated infection. J Hosp Infect 2011;79:189-93.
54. Carey AJ, Della-Latta P, Huard R, Wu F, Graham PL 3rd, Carp D, et al. Changes in the molecular epidemiological characteristics of methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit. Infect Control Hosp Epidemiol 2010;31:613-9.
55. Egea AL, Gagetti P, Lamberghini R, Faccone D, Lucero C, Vindel A, et al. New patterns of methicillinresistant Staphylococcus aureus (MRSA) clones, communityassociated MRSA genotypes behave like healthcare-associated MRSA genotypes within hospitals, Argentina. Int J Med Microbiol 2014;304:1086-99.
56. David MD, Kearns AM, Gossain S, Ganner M, Holmes A. Community-associated meticillin-resistant Staphylococcus aureus: Nosocomial transmission in a neonatal unit. J Hosp Infect 2006;64:244-50.
57. Gould IM, Girvan EK, Browning RA, MacKenzie FM, Edwards GF. Report of a hospital neonatal unit outbreak of community-associated methicillin-resistant Staphylococcus aureus. Epidemiol Infect 2009;137:1242-8.
58. Chini V, Petinaki E, Foka A, Paratiras S, Dimitracopoulos G, Spiliopoulou I. Spread of Staphylococcus aureus clinical isolates carrying Panton-Valentine leukocidin genes during a 3-year period in Greece. Clin Microbiol Infect 2006;12:29-34.
59. Larsen AR, Stegger M, Böcher S, Sørum M, Monnet DL, Skov RL. Emergence and characterization of communityassociated methicillin-resistant Staphyloccocus aureus infections in Denmark, 1999 to 2006. J Clin Microbiol 2009;47:73-8.
60. Benoit SR, Estivariz C, Mogdasy C, Pedreira W, Galiana A, Galiana A, et al. Community strains of methicillin-resistant Staphylococcus aureus as potential cause of healthcareassociated infections, Uruguay, 2002-2004. Emerg Infect Dis 2008;14:1216-23.
61. Hudson LO, Murphy CR, Spratt BG, Enright MC, Elkins K, Nguyen C, et al. Diversity of methicillin-resistant Staphylococcus aureus (MRSA) strains isolated from inpatients of 30 hospitals in Orange County, California. PLoS One 2013;8:e62117.
62. Brennan GI, Shore AC, Corcoran S, Tecklenborg S, Coleman DC, O'Connell B. Emergence of hospital- and community-associated Panton-Valentine leukocidin-positive methicillin-resistant Staphylococcus aureus genotype ST772- MRSA-V in Ireland and detailed investigation of an ST772- MRSA-V cluster in a neonatal intensive care unit. J Clin Microbiol 2012;50:841-7.
63. Inomata S, Yano H, Tokuda K, Kanamori H, Endo S, Ishizawa C, et al. Microbiological and molecular epidemiological analyses of community-associated methicillin-resistant Staphylococcus aureus at a tertiary care hospital in Japan. J Infect Chemother 2015;21:729-36.
64. Park SH, Kim SY, Lee JH, Park C, Lee DG. Communitygenotype strains of methicillin-resistant Staphylococcus aureus with high-level mupirocin resistance in a neonatal intensive care unit. Early Hum Dev 2013;89:661-5.
65. D'Souza N, Rodrigues C, Mehta A. Molecular characterization of methicillin-resistant Staphylococcus aureus with emergence of epidemic clones of sequence type (ST) 22 and ST 772 in Mumbai, India. J Clin Microbiol 2010;48:1806-11.
66. Dhawan B, Rao C, Udo EE, Gadepalli R, Vishnubhatla S, Kapil A. Dissemination of methicillin-resistant Staphylococcus aureus SCCmec type IV and SCCmec type V epidemic clones in a tertiary hospital: Challenge to infection control. Epidemiol Infect 2015;143:343-53.
67. Huijsdens XW, van Dijke BJ, Spalburg E, van Santen- Verheuvel MG, Heck ME, Pluister GN, et al. Communityacquired MRSA and pig-farming. Ann Clin Microbiol Antimicrob 2006;5:26.
68. Wulf MW, Markestein A, van der Linden FT, Voss A, Klaassen C, Verduin CM. First outbreak of methicillinresistant Staphylococcus aureus ST398 in a Dutch hospital, June 2007. Euro Surveill 2008;13. pii: 8051.
69. Bouza E. New therapeutic choices for infections caused by methicillin-resistant Staphylococcus aureus. Clin Microbiol Infect 2009;15 Suppl 7:44-52.
70. Spelman D. Fusidic acid in skin and soft tissue infections. Int J Antimicrob Agents 1999;12 Suppl 2:S59-66.
71. Holmes NE, Howden BP. What's new in the treatment of serious MRSA infection? Curr Opin Infect Dis 2014;27:471-8.
72. Tacconelli E, Kern WV. New antibiotics for skin and skinstructure infections. Lancet Infect Dis 2014;14:659-61.
73. Hussar DA, Nguyen A. Dalbavancin, tedizolid phosphate, oritavancin diphosphate, and vedolizumab. J Am Pharm Assoc 2014;54:658-62.
74. Rybak JM, Marx K, Martin CA. Early experience with tedizolid: Clinical efficacy, pharmacodynamics, and resistance. Pharmacotherapy 2014;34:1198-208.
75. Fowler VG Jr., Boucher HW, Corey GR, Abrutyn E, Karchmer AW, Rupp ME, et al. Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. N Engl J Med 2006;355:653-65.
76. Kaur DC, Chate SS. Study of antibiotic resistance pattern in methicillin resistant Staphylococcus aureus with special reference to newer antibiotic. J Glob Infect Dis 2015;7:78-84.
77. Nicholson AM, Thorns C, Wint H, Didier M, Willis R, McMorris N, et al. The detection of mupirocin resistance and the distribution of methicillin-resistant Staphylococcus aureus at the University Hospital of the West Indies, Jamaica. West Indian Med J 2010;59:509-13.
78. Rajkumari N, Mathur P, Bhardwaj N, Gupta G, Dahiya R, Behera B, et al. Resistance pattern of mupirocin in methicillin-resistant Staphylococcus aureus in trauma patients and comparison between disc diffusion and E-test for better detection of resistance in low resource countries. J Lab Physicians 2014;6:91-5.
79. Rudresh MS, Ravi GS, Motagi A, Alex AM, Sandhya P, Navaneeth BV. Prevalence of mupirocin resistance among staphylococci, its clinical significance and relationship to clinical use. J Lab Physicians 2015;7:103-7.
80. Chaturvedi P, Singh AK, Singh AK, Shukla S, Agarwal L. Prevalence of mupirocin resistant Staphylococcus aureus isolates among patients admitted to a tertiary care hospital. N Am J Med Sci 2014;6:403-7.
81. Han LL, McDougal LK, Gorwitz RJ, Mayer KH, Patel JB, Sennott JM, et al. High frequencies of clindamycin and tetracycline resistance in methicillin-resistant Staphylococcus aureus pulsed-field type USA300 isolates collected at a Boston ambulatory health center. J Clin Microbiol 2007;45:1350-2.
82. Shastry L, Rahimian J, Lascher S. Community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections in men who have sex with men in New York city. Arch Intern Med 2007;167:854-7.
83. Indian Network for Surveillance of Antimicrobial Resistance (INSAR) Group, India. Methicillin resistant Staphylococcus aureus (MRSA) in India: Prevalence and susceptibility pattern. Indian J Med Res 2013;137:363-9.
84. Thind P, Prakash SK, Wadhwa A, Garg VK, Pati B. Bacteriological profile of community-acquired pyodermas with special reference to methicillin resistant Staphylococcus aureus. Indian J Dermatol Venereol Leprol 2010;76:572-4.
85. Anupurba S, Sen MR, Nath G, Sharma BM, Gulati AK, Mohapatra TM. Prevalence of methicillin resistant Staphylococcus aureus in a tertiary referral hospital in eastern Uttar Pradesh. Indian J Med Microbiol 2003;21:49-51.
86. Kali A, Stephen S, Umadevi S, Kumar S, Joseph NM, Srirangaraj S. Changing trends in resistance pattern of methicillin resistant Staphylococcus aureus. J Clin Diagn Res 2013;7:1979-82.